Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Pain, Intractable × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Neoplasms 30 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Pain 14 Polycystic Ovary Syndrome 13 Leukemia 12 Keratosis, Actinic 10 Carcinoma, Hepatocellular 10 Uterine Cervical Neoplasms 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Leiomyoma 9 Colorectal Neoplasms 9 Carcinoma, Renal Cell 9 Brain Neoplasms 8 Neoplasm Metastasis 7 Melanoma 7 Lymphoma, Follicular 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Neuroendocrine Tumors 6 Lymphoma 6 Liver Neoplasms 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Head and Neck Neoplasms 6 Arthritis, Rheumatoid 6 Papillomavirus Infections 5 Multiple Myeloma 5 Leukemia, Myeloid, Acute 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡